BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/14/2024 12:53:06 AM | Browse: 28 | Download: 0
Publication Name World Journal of Clinical Pediatrics
Manuscript ID 93341
Country Egypt
Category Gastroenterology & Hepatology
Manuscript Type Systematic Reviews
Article Title Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons
Manuscript Source Invited Manuscript
All Author List Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy and Reem Elbeltagi
Funding Agency and Grant Number
Corresponding Author Mohammed Al-Beltagi, MBChB, MD, PhD, Academic Editor, Chairman, Professor, Research Scientist, Department of Pediatric , Faculty of Medicine, Tanta University, Al-Bahr street, The Medical Complex, Tanta ‎ 31511‎, Alghrabia, Egypt. mbelrem@hotmail.com
Key Words Fecal calprotectin; Pediatric gastrointestinal diseases; Functional gastrointestinal ‎disorders; Inflammatory bowel disease; Coeliac disease; COVID-19-induced ‎gastrointestinal disorders; Infectious gastroenteritis; Cystic fibrosis
Core Tip The core findings of this systematic review underscore the pivotal role of fecal calprotectin as a non-invasive marker for assessing intestinal inflammation in pediatric gastrointestinal diseases. Through an extensive systematic literature review, it was evident that fecal calprotectin provides valuable insights into disease activity, treatment response, and prognosis across various conditions, including functional gastrointestinal disorders, inflammatory bowel disease, coeliac disease, coronavirus disease 2019 induced gastrointestinal disorders, gastroenteritis, and cystic fibrosis-associated intestinal pathology. Despite its limitations in specificity and susceptibility to confounding factors, fecal calprotectin remains a valuable tool in pediatric gastroenterology, offering clinicians a means to diagnose, monitor, and manage gastrointestinal diseases effectively.
Citation Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World J Clin Pediatr 2024; In press
Received
2024-02-25 10:42
Peer-Review Started
2024-02-25 10:42
To Make the First Decision
Return for Revision
2024-04-19 18:07
Revised
2024-04-28 09:05
Second Decision
2024-05-13 02:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-05-14 00:53
Articles in Press
2024-05-14 00:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-05-14 08:28
ISSN 2219-2808 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com